Seeking Alpha

Geron (GERN) +5.8% premarket after BioTime (BTX) issues an open letter to GERN shareholders...

Geron (GERN) +5.8% premarket after BioTime (BTX) issues an open letter to GERN shareholders proposing a transaction between the two biopharma companies. Part of the proposal would allow GERN shareholders could own up to 45% of a new publicly traded company that would own GERN stem cell assets.
Comments (1)
  • NatGasGHshale
    , contributor
    Comments (90) | Send Message
     
    In Our Future GERN Stem cell properties will hold the keys to medical genetic disorders and their cures. It is sad that so many are against embryonic stem cell research and development... IMHO...
    18 Oct 2012, 10:39 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs